Skip navigation

Genesis


 

Brought to you by One Nucleus, the largest life science membership organisation in Europe, the Genesis Conference is an annual must attend conference, exhibition and networking forum in the heart of one of the World’s most accessible and effective deal-making locations.

Highlights of Genesis 2011 will be:

 

  • High level plenary session followed by very targeted parallel streams for biopharma and med tech

    • Online networking delivered with our partners Ya Ya Events, online partnering through our innovative ‘New Connections’ approach providing a great way to ensure you meet key targets whilst maintaining the Genesis ‘buzz'.
  •  

  • An international technology showcase including first class speakers from across Europe seeking to build academia-industry collaborations 

    • First-class exhibition area featuring more than 60 UK and overseas exhibitors

    • Gala awards dinner celebrating success in 2011
  •  

    All this makes Genesis the business hub for the international life science sector.

     

    Plenary Session

    Speakers will address the conference on topics which include the changing face of Pharma and their licensing strategies, the policy development landscape and how it can create the right bio eco-system to nurture our sector and provide insights into what is happening in key overseas target markets.

     

    Parallel Streams

    Targeted sessions tailored to addressing areas of core interest and relevance in a ‘route to revenue journey’ for biopharma, medical technology and botanical medicine innovative product development. 

     

    ABC Europe Infection & Immunity Technology Showcase

    ABC Europe is an inter-cluster project coordinated by the Milan Innovhub (Milan Chamber of Commerce) and funded by Europe Innova. It brings together 13 biotechnology clusters across Europe including One Nucleus as a leading partner.

    European researchers from academia and SMEs will be presenting their innovative technologies in the field of infectious diseases and immunity which are available for licensing or collaborative research projects.